Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Remote control of neuronal signaling.

Rogan SC, Roth BL.

Pharmacol Rev. 2011 Jun;63(2):291-315. doi: 10.1124/pr.110.003020. Epub 2011 Mar 17. Review.

2.

Optogenetics and pharmacogenetics: principles and applications.

Jiang J, Cui H, Rahmouni K.

Am J Physiol Regul Integr Comp Physiol. 2017 Dec 1;313(6):R633-R645. doi: 10.1152/ajpregu.00091.2017. Epub 2017 Aug 9. Review.

PMID:
28794102
3.

G-protein-coupled designer receptors - new chemical-genetic tools for signal transduction research.

Thiel G, Kaufmann A, Rössler OG.

Biol Chem. 2013 Dec;394(12):1615-22. doi: 10.1515/hsz-2013-0164. Review.

PMID:
23893685
4.

Engineered GPCRs as tools to modulate signal transduction.

Pei Y, Rogan SC, Yan F, Roth BL.

Physiology (Bethesda). 2008 Dec;23:313-21. doi: 10.1152/physiol.00025.2008. Review.

5.

Engineering GPCR signaling pathways with RASSLs.

Conklin BR, Hsiao EC, Claeysen S, Dumuis A, Srinivasan S, Forsayeth JR, Guettier JM, Chang WC, Pei Y, McCarthy KD, Nissenson RA, Wess J, Bockaert J, Roth BL.

Nat Methods. 2008 Aug;5(8):673-8. doi: 10.1038/nmeth.1232. Review.

6.

Novel designer receptors to probe GPCR signaling and physiology.

Wess J, Nakajima K, Jain S.

Trends Pharmacol Sci. 2013 Jul;34(7):385-92. doi: 10.1016/j.tips.2013.04.006. Epub 2013 Jun 13. Review.

7.

Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs.

Burnett CJ, Krashes MJ.

J Neurosci. 2016 Sep 7;36(36):9268-82. doi: 10.1523/JNEUROSCI.1333-16.2016. Review.

8.

Chemogenetic tools to interrogate brain functions.

Sternson SM, Roth BL.

Annu Rev Neurosci. 2014;37:387-407. doi: 10.1146/annurev-neuro-071013-014048. Epub 2014 Jun 16. Review.

PMID:
25002280
9.

DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility.

Urban DJ, Roth BL.

Annu Rev Pharmacol Toxicol. 2015;55:399-417. doi: 10.1146/annurev-pharmtox-010814-124803. Epub 2014 Sep 25. Review.

PMID:
25292433
10.

Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Martin B, Lopez de Maturana R, Brenneman R, Walent T, Mattson MP, Maudsley S.

Neuromolecular Med. 2005;7(1-2):3-36. Review.

11.

Allosteric modulation of G-protein coupled receptors.

Jensen AA, Spalding TA.

Eur J Pharm Sci. 2004 Mar;21(4):407-20. Review.

PMID:
14998571
12.

Promoting neurotrophic effects by GPCR ligands.

Jeanneteau F, Chao MV.

Novartis Found Symp. 2006;276:181-9; discussion 189-92, 233-7, 275-81. Review.

PMID:
16805430
13.

Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits.

Spangler SM, Bruchas MR.

Curr Opin Pharmacol. 2017 Feb;32:56-70. doi: 10.1016/j.coph.2016.11.001. Epub 2016 Nov 19. Review.

14.

Optogenetic user's guide to Opto-GPCRs.

Kleinlogel S.

Front Biosci (Landmark Ed). 2016 Jan 1;21:794-805. Review.

PMID:
26709806
15.

The Use of DREADDs to Deconstruct Behavior.

Whissell PD, Tohyama S, Martin LJ.

Front Genet. 2016 May 17;7:70. doi: 10.3389/fgene.2016.00070. eCollection 2016. Review.

16.

Light- and drug-activated G-protein-coupled receptors to control intracellular signalling.

Masseck OA, Rubelowski JM, Spoida K, Herlitze S.

Exp Physiol. 2011 Jan;96(1):51-6. doi: 10.1113/expphysiol.2010.055517. Epub 2010 Nov 1. Review.

17.

Optogenetic pharmacology for control of native neuronal signaling proteins.

Kramer RH, Mourot A, Adesnik H.

Nat Neurosci. 2013 Jul;16(7):816-23. doi: 10.1038/nn.3424. Epub 2013 Jun 25. Review.

18.

Yeast system as a screening tool for pharmacological assessment of g protein coupled receptors.

Minic J, Sautel M, Salesse R, Pajot-Augy E.

Curr Med Chem. 2005;12(8):961-9. Review.

PMID:
15853708
19.

The structure and function of G-protein-coupled receptors.

Rosenbaum DM, Rasmussen SG, Kobilka BK.

Nature. 2009 May 21;459(7245):356-63. doi: 10.1038/nature08144. Review.

20.

Allosteric modulators of G-protein-coupled receptors.

May LT, Christopoulos A.

Curr Opin Pharmacol. 2003 Oct;3(5):551-6. Review.

PMID:
14559102

Supplemental Content

Support Center